Stockreport

Flexion Therapeutics Announces Preliminary, Unaudited Fourth-Quarter and Full-Year 2019 Revenue and Initial Revenue Guidance for 2020

Flexion Therapeutics, Inc.  (FLXN) 
Last flexion therapeutics, inc. earnings: 11/7 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.flexiontherapeutics.com
PDF Fourth-quarter 2019 revenue estimated to be approximately $23.7 millionFull-year 2019 revenue estimated to be approximately $73 million, representing year-over-year grow [Read more]